Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.100
-0.010 (-0.47%)
Sep 18, 2024, 4:00 PM EDT - Market closed

Cellectar Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
753416419421
Upgrade
Market Cap Growth
821.80%112.09%-60.44%-57.05%346.77%186.68%
Upgrade
Enterprise Value
5335-027710
Upgrade
Last Close Price
2.112.771.716.6420.8022.50
Upgrade
PE Ratio
--0.89-0.42-1.53-2.73-1.23
Upgrade
PB Ratio
7.70-25.101.031.231.722.33
Upgrade
P/FCF Ratio
-3.26-1.02-0.63-1.79-6.75-1.80
Upgrade
P/OCF Ratio
-3.33-1.05-0.64-1.80-6.78-1.81
Upgrade
EV/EBITDA Ratio
-2.99-0.900.01-0.08-5.11-0.68
Upgrade
EV/EBIT Ratio
-2.97-0.900.01-0.08-5.06-0.67
Upgrade
EV/FCF Ratio
-3.18-1.050.01-0.09-5.53-0.81
Upgrade
Debt / Equity Ratio
0.02-0.410.040.010.010.06
Upgrade
Debt / FCF Ratio
-0.01-0.02-0.02-0.01-0.03-0.05
Upgrade
Quick Ratio
2.460.743.598.9516.043.83
Upgrade
Current Ratio
2.540.813.719.1616.264.11
Upgrade
Return on Equity (ROE)
-304.38%-536.81%-117.82%-54.92%-47.28%-126.28%
Upgrade
Return on Assets (ROA)
-91.47%-144.66%-61.26%-31.47%-26.95%-64.91%
Upgrade
Return on Capital (ROIC)
-152.45%-318.13%-72.82%-34.06%-29.49%-77.56%
Upgrade
Earnings Yield
-67.40%-111.59%-178.21%-59.46%-15.98%-66.66%
Upgrade
FCF Yield
-52.14%-97.66%-158.57%-55.98%-14.82%-55.43%
Upgrade
Buyback Yield / Dilution
-100.67%-73.22%-27.09%-180.20%-158.14%-159.12%
Upgrade
Total Shareholder Return
-100.67%-73.22%-27.09%-180.20%-158.14%-159.12%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.